Henan Lingrui Pharmaceutical Co Ltd (600285) — Cash Flow Reinvestment Rate
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Cash Flow Reinvestment Rate of 0.04x as of September 2025, reinvesting CN¥5.61 Million (capex CN¥5.61 Million ) from operating cash flow of CN¥140.12 Million. Check 600285 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Henan Lingrui Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2025)
Historical reinvestment intensity for Henan Lingrui Pharmaceutical Co Ltd across 26 annual periods. Explore Henan Lingrui Pharmaceutical Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Year-by-year capital reinvestment analysis for Henan Lingrui Pharmaceutical Co Ltd. For live market cap and broader valuation context, see how much is Henan Lingrui Pharmaceutical Co Ltd worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.18x | CN¥100.28 Million | CN¥553.88 Million | CN¥56.83 Million | ▼ -1.5% |
| 2024 | 0.18x | CN¥160.97 Million | CN¥875.86 Million | CN¥115.11 Million | ▼ -40.4% |
| 2023 | 0.31x | CN¥250.90 Million | CN¥813.43 Million | CN¥21.20 Million | ▲ +132.4% |
| 2022 | 0.13x | CN¥110.81 Million | CN¥834.91 Million | CN¥26.99 Million | ▼ -80.0% |
| 2021 | 0.66x | CN¥559.89 Million | CN¥845.69 Million | CN¥76.91 Million | ▲ +102.2% |
| 2020 | 0.33x | CN¥147.49 Million | CN¥450.53 Million | CN¥71.82 Million | ▼ -32.2% |
| 2019 | 0.48x | CN¥217.21 Million | CN¥450.15 Million | CN¥59.04 Million | ▼ -21.7% |
| 2018 | 0.62x | CN¥268.93 Million | CN¥436.25 Million | CN¥52.14 Million | ▼ -76.2% |
| 2017 | 2.59x | CN¥274.71 Million | CN¥105.97 Million | CN¥257.55 Million | ▼ -33.6% |
| 2016 | 3.90x | CN¥246.94 Million | CN¥63.26 Million | CN¥218.05 Million | ▲ +431.7% |
| 2015 | 0.73x | CN¥115.12 Million | CN¥156.82 Million | CN¥84.23 Million | ▼ -10.6% |
| 2014 | 0.82x | CN¥102.10 Million | CN¥124.32 Million | CN¥102.10 Million | ▼ -37.4% |
| 2013 | 1.31x | CN¥166.88 Million | CN¥127.27 Million | CN¥166.88 Million | ▼ -79.9% |
| 2012 | 6.51x | CN¥100.53 Million | CN¥15.43 Million | CN¥100.53 Million | ▲ +312.7% |
| 2011 | 1.58x | CN¥63.90 Million | CN¥40.49 Million | CN¥63.90 Million | ▲ +364.2% |
| 2009 | 0.34x | CN¥45.08 Million | CN¥132.61 Million | CN¥45.08 Million | ▼ -55.8% |
| 2008 | 0.77x | CN¥33.63 Million | CN¥43.72 Million | CN¥33.63 Million | ▼ -72.6% |
| 2007 | 2.81x | CN¥44.84 Million | CN¥15.99 Million | CN¥44.84 Million | ▲ +353.4% |
| 2006 | 0.62x | CN¥16.56 Million | CN¥26.76 Million | CN¥16.56 Million | ▲ +8.0% |
| 2005 | 0.57x | CN¥19.15 Million | CN¥33.43 Million | CN¥19.15 Million | ▼ -50.0% |
| 2004 | 1.14x | CN¥40.65 Million | CN¥35.51 Million | CN¥40.65 Million | ▼ -33.3% |
| 2003 | 1.72x | CN¥40.81 Million | CN¥23.79 Million | CN¥40.81 Million | ▲ +120.3% |
| 2002 | 0.78x | CN¥54.06 Million | CN¥69.41 Million | CN¥54.06 Million | ▼ -92.9% |
| 2001 | 10.93x | CN¥37.29 Million | CN¥3.41 Million | CN¥37.29 Million | ▲ +6.1% |
| 2000 | 10.31x | CN¥37.76 Million | CN¥3.66 Million | CN¥37.76 Million | ▲ +778.6% |
| 1999 | 1.17x | CN¥5.64 Million | CN¥4.81 Million | CN¥5.64 Million | — |